Rich Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows, 7 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-04-06: Reporting owner SALVADOR CAROLE A.; Form 3; Security Stock Options; Transaction Holding.
- 2017-03-30: Reporting owner Chang Ben; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-04-06: Reporting owner Chang Ben; Form 4; Security Stock Options; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-10-06: Reporting owner Chang Ben; Form 4; Security Stock Options; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-04-06 holding as of filing | SALVADOR CAROLE A. Director | 3 | Stock Options Derivative · Direct | Holding | no price filed | 2017-04-06 | ||
| 2017-03-30 | Chang Ben Director, Officer (CEO, CFO, Pres), 10% Owner | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000,000 153,246,000 owned after | $0.00 | 2017-04-06 | |
| 2015-04-06 | Chang Ben Director, Officer (CEO, CFO, Pres), 10% Owner | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000,000 53,246,000 owned after | $0.00 | 2015-04-08 | |
| 2014-10-06 | Chang Ben Director, Officer (CEO, CFO, Pres), 10% Owner | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,240,000 3,246,000 owned after | $0.00 | 2015-01-15 | |
| 2014-10-06 | Chang Ben Director, Officer (CEO, CFO, Pres), 10% Owner | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,000,000 3,006,000 owned after | $0.02 exercise price | 2014-10-14 | |
| 2013-09-17 holding as of filing | Chou David Chih-Kuang Director | 3 | Stock Options Derivative · Direct | Holding | $8.00 exercise price | 2013-09-17 | ||
| 2013-09-06 | Chang Ben Director, Officer (CEO, CFO, Pres, Sec), 10% Owner | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,200 7,200 owned after | $8.00 exercise price | 2013-09-16 |